reference/3021993

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3021993

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	8151
issn	1078-0432 1557-3265
issueIdentifier	24
pageRange	8147-8151
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	8147
bibliographicCitation	Dagher R, Li N, Abraham S, Rahman A, Sridhara R, Pazdur R. Approval summary: Docetaxel in combination with prednisone for the treatment of androgen-independent hormone-refractory prostate cancer. Clin Cancer Res. 2004 Dec 15;10(24):8147–51. doi: 10.1158/1078-0432.ccr-04-1402. PMID: 15623588.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99b4b4540618656a551d5f9d2e1fb5ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_864aa96c7f32d9e9dd1a1c995425a82c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1b6793b2c1862f93d4ffe726e12f4d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5352f0c16e7bdade60cbbe94868ec59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a58da0f3b7a4dd9e0049f85b1260b1f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55fbbeb9eb78194cc19e1a8a8e06ce69
date	2004-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-04-1402 https://pubmed.ncbi.nlm.nih.gov/15623588
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Approval summary: Docetaxel in combination with prednisone for the treatment of androgen-independent hormone-refractory prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0013954 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0026444 http://id.nlm.nih.gov/mesh/M0017465
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D009376Q000188 http://id.nlm.nih.gov/mesh/D017277 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D004347 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000230Q000556 http://id.nlm.nih.gov/mesh/D014486 http://id.nlm.nih.gov/mesh/D017430Q000378 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D043823Q000008 http://id.nlm.nih.gov/mesh/D008942Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6847 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4212 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8658 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534

Total number of triples: 73.